Dr. Gilbert Amelio, former chairman and chief executive officer of
Apple, has been named to the board of directors of
Advanced Communications Technologies Inc., an Australian-based wireless technology company.
“Dr. Amelio and his management team from Beneventure Capital LLC have entered into a management consulting contract to provide management services to the company,” a company statement released Tuesday said. “It is anticipated that Dr. Amelio will assume the role of Chairman and CEO of ACT-US upon completion of a formal contract.”
Under the agreement, Dr. Amelio and his company Beneventure Capital will help ACT-US and ACT Australia to sell its SpectruCell multiple protocol wireless base station technology in the U.S. Once Dr. Amelio completes the initial process, he will assume management control of ACT in the United States.
“Gil’s proven track record in the successful commercialization of several leading edge technologies combined with his many years of high level management experience, and his substantial experience in the telecommunications industries will provide the management expertise necessary to launch ACT on a path to becoming a major communications and infrastructure provider in the global marketplace,” said Roger May, current chairman and CEO of ACT-US.
“I feel ACT is in a strong position to become a dominant force in the global mobile wireless market,” Dr. Amelio said. “I look forward to contributing to this goal and to help generate strong returns for ACT investors.”
ACT has developed a proprietary, multiple-protocol wireless base-station called SpectruCell that allows wireless systems to use multiple mobile communications protocols all in the same base-station, totally controlled through software.
In addition to Dr. Amelio’s executive positions at Apple from November, 1994 to April of 1997, he is currently a director at SBC Communications. He holds 16 patents either singly or jointly and was co-inventor of the charge-coupled device (CCD) used in video and digital cameras.